2022美国预防医学工作组对于阿司匹林一级预防建议声明.pdf

下载文档

5
0
约7.93万字
约 8页
2023-11-07 发布于广东
举报
版权申诉
保障服务

2022美国预防医学工作组对于阿司匹林一级预防建议声明.pdf

1、本文档共8页，可阅读全部内容。
2、原创力文档（book118）网站文档一经付费（服务费），不意味着购买了该文档的版权，仅供个人/单位学习、研究之用，不得用于商业用途，未经授权，严禁复制、发行、汇编、翻译或者网络传播等，侵权必究。
3、本站所有内容均由合作方或网友上传，本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺！文档内容仅供研究参考，付费前请自行鉴别。如您付费，意味着您自己接受本站规则且自行承担风险，本站不退款、不进行额外附加服务；查看《如何避免下载的几个坑》。如果您已付费下载过本站文档，您可以点击这里二次下载。
4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等，请点击“版权申诉”（推荐），也可以打举报电话：400-050-0827(电话支持时间：9:00-18:30)。

Clinical Review & Education JAMA | US Preventive Services Task Force | RECOMMENDATION STATEMENT Aspirin Use to Prevent Cardiovascular Disease US Preventive Services Task Force Recommendation Statement US Preventive Services Task Force Editorial page 1552 IMPORTANCE Cardiovascular disease (CVD) is the leading cause of mortality in the US, Multimedia accounting for more than 1 in 4 deaths. Each year, an estimated 605 000 people in the US have a first myocardial infarction and an estimated 610 000 experience a first stroke. Related articles pages 1585 and 1598 and JAMA Patient OBJECTIVE To update its 2016 recommendation, the US Preventive Services Task Force Page page 1624 (USPSTF) commissioned a systematic review on the effectiveness of aspirin to reduce the risk Supplemental content of CVD events (myocardial infarction and stroke), cardiovascular mortality, and all-cause mortality in persons without a history of CVD. The systematic review also investigated the Related articles at